Data is not available at this time.
4Cs HD Co., Ltd. operates as a diversified specialty retailer in Japan and internationally, focusing on cosmetics, health foods, and aromatherapy products. The company generates revenue through four primary segments: mail order, retail, wholesale, and hygiene consulting. Its retail arm, under the Aroma Bloom brand, specializes in essential oils and aromatherapy products, while its wholesale division supplies drug and variety stores. The hygiene consulting segment offers sterilization devices and certification services, differentiating it from traditional retailers. 4Cs HD’s multi-channel approach—spanning physical stores, e-commerce, and B2B distribution—positions it as a niche player in Japan’s competitive consumer cyclical sector. However, its market share remains modest compared to larger retail conglomerates. The company’s focus on wellness and hygiene products aligns with growing consumer trends but faces challenges from established competitors and pricing pressures.
In FY2024, 4Cs HD reported revenue of ¥2.26 billion but recorded a net loss of ¥273 million, reflecting operational challenges. The negative operating cash flow of ¥361 million and minimal capital expenditures (¥252,000) suggest constrained liquidity and limited reinvestment. The diluted EPS of -¥31.27 underscores profitability struggles, likely due to margin compression or elevated costs in its diversified segments.
The company’s negative net income and operating cash flow indicate weak earnings power. With a market cap of ¥6.3 billion, the capital efficiency metrics are suboptimal, as evidenced by the lack of positive returns. The absence of significant capex further signals cautious or constrained resource allocation.
4Cs HD maintains a moderate financial position, with ¥836 million in cash against ¥545 million of total debt, providing a liquidity buffer. However, the negative cash flow raises concerns about sustained solvency. The debt level appears manageable relative to equity, but recurring losses could strain balance sheet flexibility.
The company’s revenue base shows potential, but profitability trends are negative. No dividends were distributed, aligning with its loss-making status. Growth may hinge on scaling its hygiene consulting segment or optimizing its retail and wholesale operations, though no clear trajectory is evident from current data.
With a beta of 0.22, the stock exhibits low volatility relative to the market. The negative earnings and lack of dividends likely weigh on investor sentiment, though the niche focus could attract thematic interest. The valuation reflects skepticism about near-term turnaround prospects.
4Cs HD’s diversified model and focus on wellness trends offer niche opportunities, but execution risks persist. Improving profitability in core segments and leveraging its hygiene consulting expertise could drive recovery. However, competitive pressures and operational inefficiencies pose headwinds, requiring strategic adjustments to stabilize performance.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |